ArticleBioinformatics advances2026
DAMFCMI: capturing cross-view interactions via hybrid attention for circRNA-MiRNA interaction prediction.
Article in Bioinformatics advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Motivation: Circular RNAs (circRNAs) and microRNAs (miRNAs) play pivotal roles in gene expression regulation, where understanding their interactions (CMIs) is essential for deciphering the molecular mechanisms behind cellular physiological and pathological states. Most existing approaches to CMI prediction are constrained by their reliance on shallow, single-view representations, while deep models typically align only on final embeddings, thereby neglecting the rich layer-wise interactions that are critical for capturing biological complexity. Results: To address these issues, we propose DAMFCMI, a novel method for CMI prediction. DAMFCMI characterizes circRNAs and miRNAs through three distinct feature views: sequence-based, attribute-based, and behavior-based features. A hybrid attention mechanism captures dependencies within individual views through multi-head self-attention and across views through cross-attention, enabling comprehensive modeling of feature interactions. Experimental results show that DAMFCMI outperforms state-of-the-art methods across three benchmark datasets. Visualization analyses demonstrate that the hybrid attention architecture enhances feature discriminability through effective multi-view feature integration. Moreover, case studies show that 13 out of 15 predicted CMIs predicted by DAMFCMI are supported by evidence in the PubMed literature, underscoring its potential for uncovering biologically relevant interactions. Availability and implementation: The data and source code are available at https://github.com/yadxbiolab/DAMFCMI.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.